Dr. Ralph Wayne Denatale, MD

Dr. Denatale practices at Connecticut Vascular Center in North Haven, Connecticut.

Dr. Denatale's NPI, 1497790026, was assigned on June 18, 2006. Dr. Denatale holds Connecticut license 027199.

Dr. Denatale's primary practice is Connecticut Vascular Center, at 280 State St, North Haven, CT 06473 in South Central Ct County. The practice phone is (203) 288-2886.

Dr. Denatale's primary practice is Connecticut Vascular Center in North Haven, Connecticut. Dr. Denatale is also affiliated with Yale New Haven Hospital. The medical group on file is Connecticut Vascular Center. Dmand AI also links Dr. Denatale to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denatale practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Denatale's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Denatale is licensed in Connecticut.

CMS data shows 462 Medicare services from Dr. Denatale across 10 procedure codes in 2024, for 227 Medicare patients. Medicare paid $44,337 for them. Every service was in an office.

CMS counts 227 Medicare patients who saw Dr. Denatale in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Denatale's median patient age at 72, with 51% women.

In 2024, Dr. Denatale wrote 232 Medicare Part D claims for 62 patients. 70% of them were for generic drugs. CMS names the drug for 187 of them, across 4 drugs with 11 or more claims each, at $54,555 in total drug cost. In 2023, CMS named 186 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Denatale for performance year 2024, reported as part of a group. Dr. Denatale accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of varicose vein removal by Dr. Denatale, more than 65% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 50 general payments to Dr. Denatale from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $760.